Moderna advances development of mRNA vaccine against Covid-19
Moderna has finalised a protocol for the Phase 3 randomised, placebo-controlled clinical study, based on the US FDA…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Jun 20
Moderna has finalised a protocol for the Phase 3 randomised, placebo-controlled clinical study, based on the US FDA…
12 Jun 20
Corvidia is involved in the research, development and commercialisation of advanced therapies for cardio-renal diseases
11 Jun 20
Opdivo is indicated for unresectable advanced, metastatic ESCC after prior fluoropyrimidine- and platinum-based chemotherapy
11 Jun 20
Vital Proteins will become a part of the Nestlé Health Science portfolio, and will benefit from a variety…
10 Jun 20
The expansion project will establish end-to-end capabilities including drug substance manufacturing, fill/finish, assembly, labelling and packaging in one…
10 Jun 20
The partnership agreement encompasses identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System
09 Jun 20
Junshi Biosciences is carrying out the development of the investigational medicine in Greater China, while Lilly is leading…
09 Jun 20
The two companies have already started enrolling patients for the initial multicentre, open-label study to evaluate the combination…
08 Jun 20
Calquence has reduced inflammation and improved clinical outcomes in 19 hospitalised patients with Covid-19 disease and severe hypoxia…
08 Jun 20
FDA indicated Recarbrio for patients aged 18 years or older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia…